These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 37402968)

  • 1. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.
    Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D
    Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
    Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
    Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
    Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
    Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis.
    Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H
    BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.
    Li J; Cao Q; Tong M
    Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
    Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
    Front Genet; 2022; 13():1039465. PubMed ID: 36338978
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and
    Wen X; Hou J; Qi T; Cheng X; Liao G; Fang S; Xiao S; Qiu L; Wei W
    Front Immunol; 2024; 15():1427475. PubMed ID: 38953023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
    Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
    Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
    Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
    Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
    Zhu S; Zhao Q; Fan Y; Tang C
    BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma.
    Shen X; Xie J; Liu S; Cai Y; Yuan S; Uehara Y; Zhu D; Zheng M
    J Thorac Dis; 2024 Aug; 16(8):5361-5378. PubMed ID: 39268091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Jia Y; Dong X; Yang F; Zhou L; Long H
    BMC Nephrol; 2024 Sep; 25(1):298. PubMed ID: 39256647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
    Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
    Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.